CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | +100.0% | 4,849 | +123.5% | 0.00% | – |
| Q2 2023 | $2 | -100.0% | 2,170 | -91.1% | 0.00% | – |
| Q3 2022 | $27,000 | -28.9% | 24,458 | -7.6% | 0.00% | – |
| Q2 2022 | $38,000 | +111.1% | 26,461 | +222.8% | 0.00% | – |
| Q1 2022 | $18,000 | +12.5% | 8,197 | +36.2% | 0.00% | – |
| Q4 2021 | $16,000 | – | 6,017 | +30.8% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 4,600 | -67.2% | 0.00% | – |
| Q2 2020 | $26,000 | +4.0% | 14,004 | -7.3% | 0.00% | – |
| Q1 2020 | $25,000 | -88.6% | 15,107 | -80.1% | 0.00% | – |
| Q4 2019 | $220,000 | – | 75,870 | +16685.4% | 0.00% | – |
| Q3 2019 | $0 | – | 452 | -2.6% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 464 | -87.3% | 0.00% | – |
| Q4 2018 | $3,000 | -90.0% | 3,641 | -27.6% | 0.00% | – |
| Q3 2018 | $30,000 | -90.3% | 5,027 | -82.6% | 0.00% | -100.0% |
| Q2 2018 | $308,000 | – | 28,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |